109 related articles for article (PubMed ID: 9929937)
61. Microbial translocation contribute to febrile episodes in adults with chemotherapy-induced neutropenia.
Wong M; Barqasho B; Ohrmalm L; Tolfvenstam T; Nowak P
PLoS One; 2013; 8(7):e68056. PubMed ID: 23874493
[TBL] [Abstract][Full Text] [Related]
62. Efficacy and Safety of Sitafloxacin in Treating Low-risk Febrile Neutropenia in Patients with Lung Cancer.
On R; Matsumoto T; Ebi N; Doi S; Ishii H; Furugen M; Fujita J; Ide M; Kishimoto J; Okamoto I; Fujita M;
JMA J; 2022 Jul; 5(3):334-340. PubMed ID: 35992295
[TBL] [Abstract][Full Text] [Related]
63. Time-to-antibiotic administration as a quality of care measure in children with febrile neutropenia: a survey of pediatric oncology centers.
McCavit TL; Winick N
Pediatr Blood Cancer; 2012 Feb; 58(2):303-5. PubMed ID: 21509930
[TBL] [Abstract][Full Text] [Related]
64. Pro-inflammatory cytokine ratios determine the clinical course of febrile neutropenia in children receiving chemotherapy.
Siegmund M; Pagel J; Scholz T; Rupp J; Härtel C; Lauten M
Mol Cell Pediatr; 2020 Jun; 7(1):5. PubMed ID: 32519027
[TBL] [Abstract][Full Text] [Related]
65. [Time to Antibiotics (TTA) - Reassessment from the German Working Group for Fever and Neutropenia in Children and Adolescents (DGPI/GPOH)].
Simon A; Lehrnbecher T; Baltaci Y; Dohna-Schwake C; Groll A; Laws HJ; Potratz J; Hufnagel M; Bochennek K
Klin Padiatr; 2023 Nov; 235(6):331-341. PubMed ID: 37751768
[TBL] [Abstract][Full Text] [Related]
66. Febrile neutropenia.
Naik JD; Sathiyaseelan SR; Vasudev NS
BMJ; 2010 Dec; 341():c6981. PubMed ID: 21169321
[No Abstract] [Full Text] [Related]
67. Diagnosis and Management of Febrile Neutropenia in Pediatric Oncology Patients-A Systematic Review.
Boeriu E; Borda A; Vulcanescu DD; Sarbu V; Arghirescu ST; Ciorica O; Bratosin F; Marincu I; Horhat FG
Diagnostics (Basel); 2022 Jul; 12(8):. PubMed ID: 35892511
[TBL] [Abstract][Full Text] [Related]
68. Plasma Microbial Cell-free DNA Next-generation Sequencing in the Diagnosis and Management of Febrile Neutropenia.
Benamu E; Gajurel K; Anderson JN; Lieb T; Gomez CA; Seng H; Aquino R; Hollemon D; Hong DK; Blauwkamp TA; Kertesz M; Blair L; Bollyky PL; Medeiros BC; Coutre S; Zompi S; Montoya JG; Deresinski S
Clin Infect Dis; 2022 May; 74(9):1659-1668. PubMed ID: 33870413
[TBL] [Abstract][Full Text] [Related]
69. Managing infections in immunosuppressed patients.
Featherstone HJ; Dale DC
Postgrad Med; 1978 Sep; 64(3):141-4, 147-8. PubMed ID: 704492
[TBL] [Abstract][Full Text] [Related]
70. The Feasibility of Host Transcriptome Profiling as a Diagnostic Tool for Microbial Etiology in Childhood Cancer Patients with Febrile Neutropenia.
Wahlund M; Sinha I; Broliden K; Saghafian-Hedengren S; Nilsson A; Berggren A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722616
[TBL] [Abstract][Full Text] [Related]
71. Genetic Sequence Variants in
Wahlund M; Lindqvist Appell M; Hed Myrberg I; Berggren A; Nilsson A
Children (Basel); 2020 Dec; 7(12):. PubMed ID: 33339376
[TBL] [Abstract][Full Text] [Related]
72. [Initial evaluation of febrile neutropenic patients: risk quantification].
Vázquez L; García JE
Enferm Infecc Microbiol Clin; 2005 Dec; 23 Suppl 5():19-23. PubMed ID: 16857152
[TBL] [Abstract][Full Text] [Related]
73. [Prolonged febrile syndrome and gastric leiomyosarcoma].
de la Figuera M; Garriga B; Marquet R; del Mar Vilar M; Vilardell M
Med Clin (Barc); 1983 Dec; 81(20):924. PubMed ID: 6664149
[No Abstract] [Full Text] [Related]
74. [Fever in tumor patients, what to do?].
Gerber AU
Schweiz Rundsch Med Prax; 1983 Nov; 72(44):1385-90. PubMed ID: 6647406
[No Abstract] [Full Text] [Related]
75. The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC "Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013.
Rapoport B; Klastersky J; Raftopoulos H; Freifeld A; Aoun M; Zinner SH; Rolston KV
Support Care Cancer; 2016 Jul; 24(7):2819-26. PubMed ID: 27098065
[No Abstract] [Full Text] [Related]
76. [Chronic benign neutropenia in children].
Kopriva F; Mihál V
Cesk Pediatr; 1990 Sep; 45(9):560-2. PubMed ID: 2078897
[No Abstract] [Full Text] [Related]
77. Management and Preventive Measures for Febrile Neutropenia.
Lucas AJ; Olin JL; Coleman MD
P T; 2018 Apr; 43(4):228-232. PubMed ID: 29622943
[TBL] [Abstract][Full Text] [Related]
78. [Clinical management for febrile neutropenia].
Tamura K
Kansenshogaku Zasshi; 2006 Jul; 80(4):358-65. PubMed ID: 16922478
[No Abstract] [Full Text] [Related]
79. Blood transcriptomics identifies immune signatures indicative of infectious complications in childhood cancer patients with febrile neutropenia.
Haeusler GM; Garnham AL; Li-Wai-Suen CS; Clark JE; Babl FE; Allaway Z; Slavin MA; Mechinaud F; Smyth GK; Phillips B; Thursky KA; Pellegrini M; Doerflinger M
Clin Transl Immunology; 2022; 11(5):e1383. PubMed ID: 35602885
[TBL] [Abstract][Full Text] [Related]
80. [The febrile forms of digestive sarcomas].
Olmer J; Carcassonne Y
Mars Med; 1967; 104(6):601-3. PubMed ID: 5618408
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]